CLINICAL_TRIALS
trial_result
· 2017-06-06
Clinical Trial Update: Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia [Phase 2]
Summary
Phase 2 trial update evaluating the efficacy and safety of midostaurin in patients with aggressive systemic mastocytosis or mast cell leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2017-06-06